Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study

OBJECTIVE: To compare the chemoresistance and survival in patients with stage IIIC or IV epithelial ovarian cancer who were treated with neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) or primary debulking surgery (PDS). The clinical characteristics of patients who benef...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yan, Li, Yuan, Zhang, Chunyu, Han, Jinsong, Liang, Huamao, Zhang, Kun, Guo, Hongyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744704/
https://www.ncbi.nlm.nih.gov/pubmed/31519183
http://dx.doi.org/10.1186/s13048-019-0562-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744704/
https://www.ncbi.nlm.nih.gov/pubmed/31519183
http://dx.doi.org/10.1186/s13048-019-0562-9

Ejemplares similares